NCT02401516

Brief Summary

ASH has a high prevalence rates and considered one of the major modifiable risk factors for cardiac vascular diseases (CVD) and brain vascular diseases (BVD) and one of the most important public health problems. Researches estimated 62% of BVD can be attributed to ASH. In Brazil, prevalence of hypertension ranged from 21.6% in 2006 to 42.4% in 2011. CVD are responsible for high frequency of hospitalization, and in 2009, 91,970 hospitalizations due to CVD cost public treasury more than 165 million reais. ASH neurological pathophysiology studies has shown that excessive activation of sympathetic autonomic nervous system (SANS) seems to have an important role in genesis and maintenance of ASH, with current studies aimed to understand this relationship. Pathways used by SANS for immediate control of BP (wich are reticulate formation, bulb and cortex) appear to be similar to pathways used for postural control reflex (reticulate formation, bulb, cortex, among others), which are also used by Postural Reprogramming Insoles (PRI) for posture adequacy. Due to this similarity in reflex activation areas, it is believed that PRI may have some effect on BP regulation. There are many ways to treat postural changes and one of them is posturology, which is based on therapeutic use of postural reprogramming insoles (PRI). PRI activates tonic-postural system, rebalancing muscles, joints and bony structures of body segments, and returning individual to an appropriate posture. The PRI is composed of a central artifact, situated in reflex zone full of somatosensory stimuli captors, which generates a frequency of vibration that promotes postural adaptation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 9, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 30, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 18, 2020

Status Verified

January 1, 2020

Enrollment Period

4.6 years

First QC Date

March 9, 2015

Last Update Submit

January 15, 2020

Conditions

Keywords

Postural Reprogramming InsoleBlood PressurePostureQuality Of LifeGeneral Functional CapacityRespiratory Muscles StrengthFlexibilityArterial Systemic Hypertension

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure Control by ABPM (Ambulatory Blood Pressure Monitoring) - mm Hg

    Subjects will undergo ABPM (Ambulatory Blood Pressure Monitoring), a technique that allows multiple indirect measurements of blood pressure for 24 or more consecutive hours with a minimum of discomfort during daily activities (MAPA, 2005). ABPM will be held by oscillometric method, BP measured every 15 minutes. ABPM will be used in accordance with ABPM I-II of IV Guideline tables. Subjects will also fill a diary of activities with data on symptoms and other situations that may modify BP. ABPM will be performed one day before PRI use to define baseline BP values, and six weeks after reassessment is performed using insole and is considered as endpoint the BP mean.

    Baseline and after 6 weeks insoles

Secondary Outcomes (19)

  • Influence of posture alterations on blood pressure control in hypertensive individuals

    Baseline

  • Composite Outcome measure - Association between Blood Pressure and Posture

    6 weeks

  • Quality of Life domains

    6 weeks

  • Description impact of High Blood Pressure by ABPM (Ambulatory Blood Pressure Monitoring)

    Baseline and 6 weeks

  • Compare estimated and predicted values of Six-minutes Walk Test.

    Baseline

  • +14 more secondary outcomes

Study Arms (2)

Reprogramming Insoles

ACTIVE COMPARATOR

EG - experimental group. Subjects will be subjected to the use of insoles with the artifact in the postural reprogramming insole that emits a electrogalvanic stream. Volunteers of this research must use the insole for at least 12 hours a day and have usage control through a daily chart.

Device: Reprogramming insoles

Neutral Insoles

PLACEBO COMPARATOR

CG - control group. Subjects will be subjected to the use of insoles likewise the ones used by EG, but instead the artifact in the postural reprogramming insole made of metal, will be made of cork.

Device: Reprogramming insoles

Interventions

1)Answer demographic, lifestyle and health questionnaire; 2)Weight and height evaluation; 3)ABPM (Ambulatory Blood Pressure Monitoring) and diary of activities assessment; 4)Postural Assessment software (SAPO), created by São Paulo's University (USP), which assesses posture through full body images of people with marked bone prominences on the body in all planes of motion. Images are captured by a Sony Cybershot 14 Megapixel camera, supported on a tripod, placed three meters away from the subject and at half its height. 5)Six-Minutes Walk Test in accordance with Britto and Souza25 and American Thoracic Society guidelines43; 6)analog manometer Globalmed® brand to assess respiratory muscle strength; 7)Dynamometer Jamar® brand to measure grip strength; 8)Wells bank to evaluate Flexibility.

Neutral InsolesReprogramming Insoles

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals diagnosed with hypertension (PAS≥140mmHg and PAD≥90mmHg), for at least two months
  • Both sexes,
  • Between 30-60 years;
  • Living in Salvador and metropolitan area,
  • Body mass index (BMI) to 29.9kg / m2,
  • In regular use of anti-hypertensive drugs

You may not qualify if:

  • Individuals with neurological diseases, mental depression, renal failure, pregnancy and diabetes mellitus associated with hypertension,
  • With a history of previous cardiovascular event (myocardial infarction, heart failure, unstable angina, peripheral arterial disease)
  • Undertake regular exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escola Bahiana de Medicina E Saúde Pública

Salvador, Estado de Bahia, 40.000-000, Brazil

Location

Related Publications (20)

  • Kavounoudias A, Roll R, Roll JP. The plantar sole is a 'dynamometric map' for human balance control. Neuroreport. 1998 Oct 5;9(14):3247-52. doi: 10.1097/00001756-199810050-00021.

    PMID: 9831459BACKGROUND
  • Ribot-Ciscar E, Roll JP. Ago-antagonist muscle spindle inputs contribute together to joint movement coding in man. Brain Res. 1998 Apr 27;791(1-2):167-76. doi: 10.1016/s0006-8993(98)00092-4.

    PMID: 9593876BACKGROUND
  • Villechevrolle, O. Influence des semelles of reprogrammation posturale globale sur les tests oculomoteurs réalisés sur une des sujets présentant disfonction cranio-mandibulaire.Thèse, Nantes, 1994a

    BACKGROUND
  • Villechevrolle, O. Influence des semelles of reprogrammation posturale globale sur le test de Fukuda. Diplôme d'Université mémoire of the Parodontologie et d'occluso, Nantes, 1994b.

    BACKGROUND
  • Mallong SP. Étude prospective longitudinal suivi par of pacientes douloureux au cours d'une Reprogrammation posturale Globale (RPG). Résonances Européennes du Rachis. 2006; 14 (42): 1753-6.

    BACKGROUND
  • Brazilian Society of Cardiology / Brazilian Society of Hypertension / Brazilian Society of Nephrology. VI Brazilian Guidelines on Hypertension. Arq Bras Cardiol 2010; 95 (1 suppl.1): 1-51

    BACKGROUND
  • Ferreira SR, Moura EC, Malta DC, Sarno F. Frequency of arterial hypertension and associated factors: Brazil, 2006. Rev Saude Publica. 2009 Nov;43 Suppl 2:98-106. doi: 10.1590/s0034-89102009000900013. English, Portuguese.

    PMID: 19936504BACKGROUND
  • Piccini RX, Facchini LA, Tomasi E, Siqueira FV, Silveira DS, Thume E, Silva SM, Dilelio AS. Promotion, prevention and arterial hypertension care in Brazil. Rev Saude Publica. 2012 Jun;46(3):543-50. doi: 10.1590/s0034-89102012005000027. Epub 2012 Apr 17. English, Portuguese.

    PMID: 22510974BACKGROUND
  • Lopes MC, Marcon SS. [Arterial hypertension in the family: the need for family care]. Rev Esc Enferm USP. 2009 Jun;43(2):343-50. doi: 10.1590/s0080-62342009000200013. Portuguese.

    PMID: 19655675BACKGROUND
  • Schulz RB, Rossignoli P, Correr CJ, Fernandez-Llimos F, Toni PM. Validation of the short form of the Spanish hypertension quality of life questionnaire (MINICHAL) for Portuguese (Brazil). Arq Bras Cardiol. 2008 Feb;90(2):127-31. doi: 10.1590/s0066-782x2008000200010. English, Portuguese.

    PMID: 18392385BACKGROUND
  • Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.

    PMID: 9626712BACKGROUND
  • Colne P, Frelut ML, Peres G, Thoumie P. Postural control in obese adolescents assessed by limits of stability and gait initiation. Gait Posture. 2008 Jul;28(1):164-9. doi: 10.1016/j.gaitpost.2007.11.006. Epub 2008 Jan 10.

    PMID: 18191568BACKGROUND
  • Roll JP, Bergenheim M, Ribot-Ciscar E. Proprioception Muscle afferents Sensory coding

    RESULT
  • Kavounoudias A, Roll R, Roll JP. Foot sole and ankle muscle inputs contribute jointly to human erect posture regulation. J Physiol. 2001 May 1;532(Pt 3):869-78. doi: 10.1111/j.1469-7793.2001.0869e.x.

  • Roll R, Kavounoudias A, Roll JP. Cutaneous afferents from human plantar sole contribute to body posture awareness. Neuroreport. 2002 Oct 28;13(15):1957-61. doi: 10.1097/00001756-200210280-00025.

  • Grassi G, Seravalle G, Quarti-Trevano F. The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol. 2010 May;95(5):581-6. doi: 10.1113/expphysiol.2009.047381. Epub 2009 Dec 11.

  • Fisher JP, Fadel PJ. Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol. 2010 May;95(5):572-80. doi: 10.1113/expphysiol.2009.047332. Epub 2010 Mar 19.

  • Tsioufis C, Kordalis A, Flessas D, Anastasopoulos I, Tsiachris D, Papademetriou V, Stefanadis C. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011 Jan 20;2011:642416. doi: 10.4061/2011/642416.

  • Bruno RM, Ghiadoni L, Seravalle G, Dell'oro R, Taddei S, Grassi G. Sympathetic regulation of vascular function in health and disease. Front Physiol. 2012 Jul 24;3:284. doi: 10.3389/fphys.2012.00284. eCollection 2012.

  • Cavalcante MA, Bombig MT, Luna Filho B, Carvalho AC, Paola AA, Povoa R. Quality of life of hypertensive patients treated at an outpatient clinic. Arq Bras Cardiol. 2007 Oct;89(4):245-50. doi: 10.1590/s0066-782x2007001600006. English, Portuguese.

Related Links

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • ANA MARICE T LADEIA, Doctorade

    ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHYSICAL THERAPIST AND PROFESSOR AT ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA

Study Record Dates

First Submitted

March 9, 2015

First Posted

March 30, 2015

Study Start

May 1, 2014

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

January 18, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations